Latest Leverage News

Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.

Manhattan Gold has contracted Northspan Explorations for a 4,000m reverse circulation drilling campaign at its Hook Lake Project in Nunavut, aiming to validate high-grade gold and polymetallic targets across a vast underexplored greenstone belt.

Triangle Energy has secured joint funding with Tetragon and Winchester Energy to undertake a strategic exploration study in Indonesia, potentially paving the way for a new production sharing contract.

Felix Gold has secured a bulk sampling permit to extract 1,600 tons of high-grade antimony ore from its Treasure Creek project in Alaska, marking a pivotal step towards near-term production. The permit supports multiple production pathways, including toll treatment in 2026 and a dedicated smelter by 2027.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

Enlitic has secured a $1.5 million contract to migrate over 71 million clinical files for Penn Medicine Doylestown Health, reinforcing its foothold in the US healthcare IT sector.

Synlait confirms the imminent sale of its North Island assets to Abbott for NZ$307 million, aiming to reset its balance sheet amid a challenging half-year result. The company unveils a recovery roadmap focused on stabilising and scaling its core operations.

Synlait Milk Limited has reported a significant half-year loss driven by manufacturing setbacks and market pressures, alongside a strategic recovery roadmap focused on asset sales and operational overhaul.

Noronex Limited announces the resignation of CEO Victor Rajasooriar, who will transition to Wiluna Mining Corporation, while the Board steps in to manage ongoing exploration projects in Botswana and Namibia.

Aldoro Resources has finalised the sale of its Wyemandoo Project to Coppermoly, receiving A$100,000 and redirecting its efforts towards its flagship Kameelburg project.

Renascor Resources reports significant cobalt and copper mineralisation from its recent Bulloo Creek drilling program, while advancing exploration across South Australia’s Olary, Marree, Wooltana, and Tumby Bay projects.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.